Corvus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $6.15 |
Previous Close | $6.12 |
Day Range | $6.13-$6.49 |
52W Range | $2.54-$10 |
Market Cap | $450M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • 2 months ago
Corvus plans Phase II trial for soquelitinib in atopic dermatitis, targeting 200 patients with 12-week treatment window
Yahoo Finance • 2 months ago
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
Yahoo Finance • 3 months ago
Corvus Q1 2025 presentation: Phase 1 atopic dermatitis data drives stock surge
Yahoo Finance • 3 months ago
Tuesday's Insider Activity: Major Buys and Sells Shake Up Markets
About
CEO | Dr. Richard A. Miller M.D. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 31 |
